ATAI Life Sciences NV (FRA:9VC) Net Change in Cash : €-140.99 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is ATAI Life Sciences NV Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

ATAI Life Sciences NV's Net Change in Cash for the three months ended in Mar. 2024 was €-10.27 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 was €-140.99 Mil.

ATAI Life Sciences NV Net Change in Cash Historical Data

The historical data trend for ATAI Life Sciences NV's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ATAI Life Sciences NV Net Change in Cash Chart

ATAI Life Sciences NV Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

20.83

55.23

234.54

-162.04

-133.50

ATAI Life Sciences NV Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Change in Cash	Get a 7-Day Free Trial													-4.42	-41.35	-60.53	-28.85	-10.27

ATAI Life Sciences NV Net Change in Cash Calculation

ATAI Life Sciences NV's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-77.136	+	-48.872	+	-7.662	+	0.173
	=	-133.50

ATAI Life Sciences NV's Net Change in Cash for the quarter that ended in Mar. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -20.767 + 10.553 + 0 + -0.059

= -10.27

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-140.99 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ATAI Life Sciences NV Net Change in Cash Related Terms
Thank you for viewing the detailed overview of ATAI Life Sciences NV's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

ATAI Life Sciences NV (FRA:9VC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ATAI Life Sciences NV (FRA:9VC) » Definitions » Net Change in Cash

Comparable Companies

LCTX RENB AEON FATE ZURA IMRX HUMA ENTA SCPH CRMD OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX

Traded in Other Exchanges

ATAI:USA ATAI:Mexico

Address

Wallstraße 16, Berlin, BB, DEU, 10179

Website

https://www.atai.life

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.

ATAI Life Sciences NV (FRA:9VC) Headlines

No Headlines